The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Social Defeat Stress-Induced Behavioral Responses are Mediated by the Endogenous Kappa Opioid System
Open accessAbstract
Previous studies have demonstrated that repeated forced-swim stress-induced behaviors (including analgesia, immobility, and increased drug reward) were mediated by the release of endogenous prodynorphin-derived opioid peptides and subsequent activation of the kappa opioid receptor (KOR). We tested the generality of these effects using a different type of stressful situation: repeated social defeat. C57Bl/6 mice subjected to social defeat stress (SDS) over 3 days showed a characteristic stress-induced immobility and defeated-postural response, as well as stress-induced analgesia (SIA). Daily pretreatment with the KOR antagonist nor-binaltorphimine (nor-BNI, 10 mg/kg, i.p.) blocked the SIA and significantly reduced the stress-induced immobility on the second and third days of SDS exposure. In contrast, prodynorphin gene-disrupted mice showed no significant increase in immobility, socially defeated postures, or SIA following repeated exposure to SDS. Since both stress and the kappa opioid system can modulate the response to drugs of abuse, we tested the effects of SDS on cocaine-conditioned place preference (CPP). SDS-exposed mice conditioned with cocaine (15 mg/kg, s.c.) showed significant potentiation of place-preference for the drug-paired chamber over the responses of unstressed mice. Nor-BNI pretreatment blocked stress-induced potentiation of cocaine-CPP. Consistent with this result, mice lacking the prodynorphin gene did not show stress-induced potentiation of cocaine-CPP, whereas wild-type littermates did. The findings suggest that chronic SDS may activate the kappa opioid system to produce analgesia, immobility, social defeat postures, and resulting in a potentiation of the acute rewarding properties of cocaine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In some species or strains within species, however, tonic immobility may be the front-line defense response to extreme threat, even when the animal is not restrained.8,26,86”
From Fear and the Defense Cascade (2015) · cites this paper as [86]
Citations
Cites
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,005
Regulation of cocaine reward by CREB
Carlezon, W. A., Thome, J., Olson, V. G., Lane-Ladd, S. B., Brodkin, E. S., Hiroi, N., Duman, R. S., Neve, R. L., & Nestler, E. J. (1998) · Science · doi:10.1126/science.282.5397.2272 · Cited by 767
Stress-induced relapse to heroin and cocaine seeking in rats: a review
Shaham, Y., Erb, S. M., & Stewart, J. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00024-2 · Cited by 704
Pliakas, A. M., Carlson, R. R., Neve, R. L., Konradi, C., Nestler, E. J., & Carlezon, W. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07397.2001 · Cited by 509
McLaughlin, J. P., Marton-Popovici, M., & Chavkin, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05674.2003 · Cited by 505
Self-citationSocial defeat as a stressor in humans
Björkqvist, K. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00490-5 · Cited by 502
Lucki, I., Dalvi, A., & Mayorga, A. J. (2001) · Psychopharmacology · doi:10.1007/s002130100694 · Cited by 501
Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats
Mague, S. D., Pliakas, A. M., Todtenkopf, M. S., Tomasiewicz, H. C., Zhang, Y., Stevens, W. C., Jones, R. M., Portoghese, P. S., & Carlezon, W. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046433 · Cited by 485
Flagged first, then by citations
1 of the 43 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307
Rácz, I., & Zimmer, A. (2006) · doi:10.1002/9783527611942.ch9 · Cited by 1,659
The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System
Land, B. B., Bruchas, M. R., Lemos, J. C., Xu, M., Melief, E. J., & Chavkin, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4458-07.2008 · Cited by 601
Self-citationHistone Deacetylase 5 Epigenetically Controls Behavioral Adaptations to Chronic Emotional Stimuli
Renthal, W., Maze, I., Krishnan, V., Covington, H. E., Xiao, G., Kumar, A., Russo, S. J., Graham, A., Tsankova, N., Kippin, T. E., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.09.032 · Cited by 599
The Development and Maintenance of Drug Addiction
Wise, R. A., & Koob, G. F. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.261 · Cited by 617
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors
Bruchas, M. R., Land, B. B., & Chavkin, C. (2010) · Brain Research · doi:10.1016/j.brainres.2009.08.062 · Cited by 544
Self-citationOpioid receptors: Distinct roles in mood disorders
Lutz, P.-E., & Kieffer, B. L. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.11.002 · Cited by 542
Animal Models of Depression: Molecular Perspectives
Krishnan, V., & Nestler, E. J. (2011) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2010_108 · Cited by 528
Addiction as a stress surfeit disorder
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.024 · Cited by 483
Kozlowska, K., Walker, P., McLean, L., & Carrive, P. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000065 · Cited by 468
Dynorphin, stress, and depression
Knoll, A. T., & Carlezon, W. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.074 · Cited by 465
The dark side of emotion: the addiction perspective
Koob, G. F. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.044 · Cited by 433
The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse
Wee, S., & Koob, G. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1825-8 · Cited by 398
Addiction is a Reward Deficit and Stress Surfeit Disorder
Koob, G. F. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00072 · Cited by 397
Social stress, therapeutics and drug abuse: Preclinical models of escalated and depressed intake
MICZEK, K., YAP, J., & COVINGTONIII, H. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.07.006 · Cited by 338
Negative reinforcement in drug addiction: the darkness within
Koob, G. F. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.03.011 · Cited by 364
Kinase cascades and ligand-directed signaling at the kappa opioid receptor
Bruchas, M. R., & Chavkin, C. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1806-y · Cited by 321
Self-citationAddiction and Stress: An Allostatic View
Koob, G. F., & Schulkin, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.008 · Cited by 315
Land, B. B., Bruchas, M. R., Schattauer, S., Giardino, W. J., Aita, M., Messinger, D., Hnasko, T. S., Palmiter, R. D., & Chavkin, C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910705106 · Cited by 301
Self-citationCastro, D. C., & Bruchas, M. R. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.003 · Cited by 306
Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates κ-Opioid-Dependent Dysphoria
Bruchas, M. R., Land, B. B., Aita, M., Xu, M., Barot, S. K., Li, S., & Chavkin, C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3769-07.2007 · Cited by 282
Self-citationRole of kappa-opioid receptors in stress and anxiety-related behavior
Veer, A. V., & Carlezon, W. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3195-5 · Cited by 262
Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system
Redila, V. A., & Chavkin, C. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1122-y · Cited by 234
Self-citationThe Kappa Opioid Receptor: From Addiction to Depression, and Back
Lalanne, L., Ayrancı, G., Kieffer, B. L., & Lutz, P.-É. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00170 · Cited by 236
kappa-Opioid receptor signaling and brain reward function
Bruijnzeel, A. W. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.09.008 · Cited by 214
Watt, D. F., & Panksepp, J. (2009) · Neuropsychoanalysis · doi:10.1080/15294145.2009.10773593 · Cited by 216
Panksepp, J., & Watt, D. (2011) · Psychiatry: Interpersonal and Biological Processes · doi:10.1521/psyc.2011.74.1.5 · Cited by 207
Drug-Induced Conditioned Place Preference and Its Practical Use in Substance Use Disorder Research
McKendrick, G., & Graziane, N. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.582147 · Cited by 218
Pizzagalli, D. A. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220423 · Cited by 214
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches
Peciña, M., Karp, J. F., Mathew, S. J., Todtenkopf, M. S., Ehrich, E. W., & Zubieta, J.-K. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0117-2 · Cited by 197
High‐throughput behavioral phenotyping in the expanded panel of BXD recombinant inbred strains
Philip, V. M., Duvvuru, S., Gomero, B., Ansah, T.-A., Blaha, C. D., Cook, M. N., Hamre, K. M., Lariviere, W. R., Matthews, D. B., Mittleman, G., et al. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00540.x · Cited by 186
Hypothesis: social defeat is a risk factor for schizophrenia?
Selten, J., & Cantor‐Graae, E. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.51.s9 · Cited by 177
Donahue, R. J., Muschamp, J. W., Russo, S. J., Nestler, E. J., & Carlezon, W. A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.12.014 · Cited by 161
“The ability of ΔFosB overexpression to block the anhedonic effects of both CSDS and kappa-opioid receptor agonists suggests potential overlap in molecular mechanisms, as proposed previously (75,76).”
BackgroundIndividual Differences and Social Influences on the Neurobehavioral Pharmacology of Abused Drugs
Bardo, M. T., Neisewander, J. L., & Kelly, T. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005124 · Cited by 167
Suicide Risk and Addiction: The Impact of Alcohol and Opioid Use Disorders
Rizk, M., Herzog, S., Dugad, S., & Stanley, B. (2021) · Current Addiction Reports · doi:10.1007/s40429-021-00361-z · Cited by 195
Development of κ Opioid Receptor Antagonists
Carroll, F. I., & Carlezon, W. A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301783x · Cited by 166
Anesthesia and Analgesia for Laboratory Rodents
Gaertner, D. J., Hallman, T., Hankenson, F. C., & Batchelder, M. (2008) · Elsevier eBooks · doi:10.1016/b978-012373898-1.50014-0 · Cited by 164
The dynorphin/κ-opioid receptor system and its role in psychiatric disorders
Tejeda, H. A., Shippenberg, T. S., & Henriksson, R. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0844-x · Cited by 161
Kappa-opioid ligands in the study and treatment of mood disorders
Carlezon, W. A., Béguin, C., Knoll, A. T., & Cohen, B. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.008 · Cited by 156
Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions
Fricker, L. D., Margolis, E. B., Gomes, I., & Devi, L. A. (2020) · Molecular Pharmacology · doi:10.1124/mol.120.119388 · Cited by 162
Rose, J. H., Karkhanis, A. N., Chen, R., Gioia, D., Lopez, M. F., Becker, H. C., McCool, B. A., & Jones, S. R. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv127 · Cited by 136
Charbogne, P., Kieffer, B. L., & Befort, K. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.028 · Cited by 161
Carey, A. N., Borozny, K., Aldrich, J. V., & McLaughlin, J. P. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.007 · Cited by 140
Self-citationKnoll, A. T., Muschamp, J. W., Daws, S. E., Ferguson, D., Dietz, D., Meloni, E. G., Carroll, F. I., Nestler, E. J., Konradi, C. L., & Carlezon, W. A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.017 · Cited by 143
A review on animal models for screening potential anti-stress agents
Jaggi, A. S., Bhatia, N., Kumar, N., Singh, N., Anand, P., & Dhawan, R. K. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0770-6 · Cited by 134
Molecular and genetic substrates linking stress and addiction
Briand, L. A., & Blendy, J. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.11.002 · Cited by 125
Neuroanatomical characterization of endogenous opioids in the bed nucleus of the stria terminalis
Poulin, J.-F., Arbour, D., Laforest, S., & Drolet, G. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.021 · Cited by 125
Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in Wistar Kyoto Rats
Carr, G. V., Bangasser, D. A., Bethea, T. T., Young, M., Valentino, R. J., & Lucki, I. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.183 · Cited by 124
κ-Opioid Receptors within the Nucleus Accumbens Shell Mediate Pair Bond Maintenance
Resendez, S. L., Kuhnmuench, M., Krzywosinski, T., & Aragona, B. J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5779-11.2012 · Cited by 110
“Voles have higher baseline analgesia compared to mice (Table 2), and higher doses of the -opioid receptor agonist were needed to enhance antinociception (Tables 2, 3) (McLaughlin et al., 2006b).”
BackgroundMethodResultInfluentialStress-induced modulation of pain: Role of the endogenous opioid system
Ferdousi, M. I., & Finn, D. P. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.07.002 · Cited by 116
Loss of Environmental Enrichment Increases Vulnerability to Cocaine Addiction
Nader, J., Claudia, C., Rawas, R. E., Favot, L., Jaber, M., Thiriet, N., & Solinas, M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.2 · Cited by 178
Nocjar, C., Zhang, J., Feng, P., & Panksepp, J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.033 · Cited by 111
Kreibich, A., Reyes, B. A. S., Curtis, A. L., Ecke, L. E., Chavkin, C., Bockstaele, E. J. V., & Valentino, R. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0390-08.2008 · Cited by 104
Self-citationPizzagalli, D. A., Smoski, M. J., Ang, Y., Whitton, A. E., Sanacora, G., Mathew, S. J., Nürnberger, J. I., Lisanby, S. H., Iosifescu, D. V., Murrough, J. W., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0738-4 · Cited by 104
Valdez, G. R., Platt, D. M., Rowlett, J. K., Rüedi-Bettschen, D., & Spealman, R. D. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125484 · Cited by 99
The opioid system in depression
Jelen, L. A., Stone, J. M., Young, A. H., & Mehta, M. A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104800 · Cited by 108
Epigenetic Regulation of the Kappa Opioid Receptor by Child Abuse
Lutz, P.-E., Gross, J. A., Dhir, S. K., Maussion, G., Yang, J., Bramoulle, A., Meaney, M. J., & Turecki, G. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.07.012 · Cited by 96
Targeting opioid dysregulation in depression for the development of novel therapeutics
Browne, C. A., & Lucki, I. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.009 · Cited by 100
Opioid partial agonist buprenorphine dampens responses to psychosocial stress in humans
Bershad, A. K., Jaffe, J. H., Childs, E., & de Wit, H. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.12.004 · Cited by 98
Dynorphin–Still an Extraordinarily Potent Opioid Peptide
Chavkin, C. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.083337 · Cited by 99
Self-citationEndogenous κ Opioid Activation Mediates Stress-Induced Deficits in Learning and Memory
Carey, A. N., Lyons, A. M., Shay, C. F., Dunton, O., & McLaughlin, J. P. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6146-08.2009 · Cited by 91
Self-citationEndogenous opiates and behavior: 2006
Bodnar, R. J. (2007) · Peptides · doi:10.1016/j.peptides.2007.09.002 · Cited by 91
Effects of opioid- and non-opioid analgesics on responses to psychosocial stress in humans
Bershad, A. K., Miller, M. A., Norman, G. J., & de Wit, H. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.04.009 · Cited by 92
Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction
Gerra, G., Leonardi, C., Cortese, E., D'Amore, A., Lucchini, A., Strepparola, G., Serio, G., Farina, G., Magnelli, F., Zaimovic, A., et al. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30510 · Cited by 90
Morani, A. S., Kivell, B. M., Prisinzano, T. E., & Schenk, S. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.09.002 · Cited by 89
Neisewander, J. L., Peartree, N. A., & Pentkowski, N. S. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2853-3 · Cited by 87
Schindler, A. G., Li, S., & Chavkin, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.67 · Cited by 85
Self-citationEffects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice
Falcón, E., Maier, K. L., Robinson, S. A., Hill‐Smith, T. E., & Lucki, I. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3723-y · Cited by 87
Bruchas, M. R., Xu, M., & Chavkin, C. (2008) · Neuroreport · doi:10.1097/wnr.0b013e32830dd655 · Cited by 82
Self-citationSchafer, S. M., Geuter, S., & Wager, T. D. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.008 · Cited by 79
Warren, B. L., Mazei‐Robison, M. S., Robison, A. J., & Iñiguez, S. D. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.004 · Cited by 78
Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal
Pomrenze, M. B., Pinto, D. F. C., Neumann, P. A., Llorach, P., Tucciarone, J., Morishita, W., Eshel, N., Heifets, B. D., & Malenka, R. C. (2022) · Neuron · doi:10.1016/j.neuron.2022.09.024 · Cited by 79
Macedo, G. C., Morita, G. M., Domingues, L. P., Favoretto, C. A., Suchecki, D., & Quadros, I. M. (2017) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.10.007 · Cited by 79
Burke, A. R., Watt, M. J., & Forster, G. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.008 · Cited by 74
Blockade of ethanol reward by the kappa opioid receptor agonist U50,488H
Logrip, M. L., Janak, P. H., & Dorit Ron, A. (2009) · Alcohol · doi:10.1016/j.alcohol.2009.05.001 · Cited by 72
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders
Jacobson, M. L., Browne, C. A., & Lucki, I. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023317 · Cited by 70
Carr, G. V., & Lucki, I. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1832-9 · Cited by 68
A New Model of Neonatal Stress Which Produces Lasting Neurobehavioral Effects in Adult Rats
McPherson, R. J., Gleason, C. A., Mascher-Denen, M., Chan, M., Kellert, B., & Juul, S. E. (2007) · Neonatology · doi:10.1159/000100084 · Cited by 70
Antagonists of the kappa opioid receptor
Urbano, M., Guerrero, M. A., Rosen, H., & Roberts, E. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.040 · Cited by 69
The opioid system and the social brain: implications for depression and suicide
Lutz, P., Courtet, P., & Calati, R. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24269 · Cited by 53
Kallupi, M., Wee, S., Edwards, S., Whitfield, T. W., Oleata, C. S., Luu, G., Schmeichel, B. E., Koob, G. F., & Roberto, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.04.028 · Cited by 65
Jackson, K. J., McLaughlin, J. P., Carroll, F. I., & Damaj, M. I. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2716-y · Cited by 65
Self-citationDonahue, R. J., Landino, S. M., Golden, S. A., Carroll, F. I., Russo, S. J., & Carlezon, W. A. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000155 · Cited by 67
Robles, C. F., McMackin, M. Z., Campi, K. L., Doig, I. E., Takahashi, E. Y., Pride, M. C., & Trainor, B. C. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.01.003 · Cited by 67
Koob, G. F. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4484-6 · Cited by 73
Effects of buprenorphine on responses to social stimuli in healthy adults
Bershad, A. K., Seiden, J. A., & de Wit, H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.09.011 · Cited by 64
Xu, K., Seo, D., Hodgkinson, C. A., Hu, Y., Goldman, D. A., & Sinha, R. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.62 · Cited by 63
Social defeat stress and escalation of cocaine and alcohol consumption: Focus on CRF
Newman, E. L., Leonard, M. Z., Arena, D. T., de Almeida, R. M. M., & Miczek, K. A. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.09.007 · Cited by 70
Berger, A. L., Williams, A. M., McGinnis, M. M., & Walker, B. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.229 · Cited by 66
Siciliano, C. A., Calipari, E. S., Carlson, V. C. C., Helms, C. M., Lovinger, D. M., Grant, K. A., & Jones, S. R. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4820-14.2015 · Cited by 62
Aversive motivation and the maintenance of monogamous pair bonding
Resendez, S. L., & Aragona, B. J. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2012-0068 · Cited by 58
Grimwood, S., Lu, Y., Schmidt, A. W., Vanase-Frawley, M. A., Sawant‐Basak, A., Miller, E. L., McLean, S., Freeman, J., Wong, S., McLaughlin, J. P., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.185108 · Cited by 58
Self-citationSchattauer, S. S., Bedini, A., Summers, F., Reilly-Treat, A., Andrews, M. M., Land, B. B., & Chavkin, C. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009592 · Cited by 61
Self-citationA role for the mu opioid receptor in the antidepressant effects of buprenorphine
Robinson, S. A., Erickson, R. L., Browne, C. A., & Lucki, I. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.10.050 · Cited by 58
Stress and rodent models of drug addiction: role of VTA–accumbens–PFC–amygdala circuit
Yap, J. J., & Miczek, K. A. (2008) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2009.03.010 · Cited by 61
Veer, A. V., Yano, J. M., Carroll, F. I., Cohen, B. M., & Carlezon, W. A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.151 · Cited by 58
Reversal of Stress-Induced Social Interaction Deficits by Buprenorphine
Browne, C. A., Falcón, E., Robinson, S. A., Berton, O., & Lucki, I. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx079 · Cited by 57
Bérubé, P., Laforest, S., Bhatnagar, S., & Drolet, G. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.04.009 · Cited by 59
Naltrexone alters the processing of social and emotional stimuli in healthy adults
Wardle, M. C., Bershad, A. K., & de Wit, H. (2015) · Social Neuroscience · doi:10.1080/17470919.2015.1136355 · Cited by 52
Social interaction reward: A resilience approach to overcome vulnerability to drugs of abuse
Rawas, R. E., Amaral, I. M., & Hofer, A. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.06.008 · Cited by 58
Metadata
- Authors
- McLaughlin, J. P., Li, S., Valdez, J., Chavkin, T. A., & Chavkin, C.
- Affiliations
- Northeastern University (US)
- University of Washington (US)
- Corresponding author
- Chavkin, Charles
- Venue
- Neuropsychopharmacology
- Published
- 2005-08-17
- Volume
- 31
- Issue
- 6
- Pages
- 1241-1248
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC2096774
- OpenAlex
- W2023872238
- Cited by
- 253
- References
- 43
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 5 · 2023: 11 · 2022: 11 · 2021: 9 · 2020: 16 · 2019: 10 · 2018: 26 · 2017: 12 · 2016: 10 · 2015: 17 · 2014: 12 · 2013: 14 · 2012: 21
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5p01da015916-05)
- U.S. Public Health Service
- National Institute on Drug Abuse (R01DA11672, P01DA15916, R01DA016898, P01-DA015916, R03DA016656, R01DA011672, R03 DA 16656)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- social defeat stress, kappa opioid receptor, nor-binaltorphimine, prodynorphin, stress-induced analgesia, immobility, cocaine conditioned place preference, endogenous opioids, chronic stress
- MeSH terms
- Analysis of Variance, Anesthetics, Local, Animals, Behavior, Animal, Cocaine, Conditioning, Operant, Enkephalins, Male, Mice, Inbred C57BL, Naltrexone, Narcotic Antagonists, Pain Measurement, Protein Precursors, Reaction Time, Social Behavior, Stress, Psychological, Receptors, Opioid, kappa, Mice, Knockout, Immobility Response, Tonic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review